Microglial activation in young adults with autism spectrum disorder.

CONTEXT A growing body of evidence suggests that aberrant immunologic systems underlie the pathophysiologic characteristics of autism spectrum disorder (ASD). However, to our knowledge, no information is available on the patterns of distribution of microglial activation in the brain in ASD. OBJECTIVES To identify brain regions associated with excessively activated microglia in the whole brain, and to examine similarities in the pattern of distribution of activated microglia in subjects with ASD and control subjects. DESIGN Case-control study using positron emission tomography and a radiotracer for microglia--[11C](R)-(1-[2-chrorophynyl]-N-methyl-N-[1-methylpropyl]-3 isoquinoline carboxamide) ([11C](R)-PK11195). SETTING Subjects recruited from the community. PARTICIPANTS Twenty men with ASD (age range, 18-31 years; mean [SD] IQ, 95.9 [16.7]) and 20 age- and IQ-matched healthy men as controls. Diagnosis of ASD was made in accordance with the Autism Diagnostic Observation Schedule and the Autism Diagnostic Interview-Revised. MAIN OUTCOME MEASURES Regional brain [11C](R)-PK11195 binding potential as a representative measure of microglial activation. RESULTS The [11C](R)-PK11195 binding potential values were significantly higher in multiple brain regions in young adults with ASD compared with those of controls (P < .05, corrected). Brain regions with increased binding potentials included the cerebellum, midbrain, pons, fusiform gyri, and the anterior cingulate and orbitofrontal cortices. The most prominent increase was observed in the cerebellum. The pattern of distribution of [11C](R)-PK11195 binding potential values in these brain regions of ASD and control subjects was similar, whereas the magnitude of the [11C](R)-PK11195 binding potential in the ASD group was greater than that of controls in all regions. CONCLUSIONS Our results indicate excessive microglial activation in multiple brain regions in young adult subjects with ASD. The similar distribution pattern of regional microglial activity in the ASD and control groups may indicate augmented but not altered microglial activation in the brain in the subjects with ASD.

[1]  S Baron-Cohen,et al.  Sex-specific serum biomarker patterns in adults with Asperger's syndrome , 2011, Molecular Psychiatry.

[2]  Takahiro A. Kato,et al.  Anti-Inflammatory properties of antipsychotics via microglia modulations: are antipsychotics a 'fire extinguisher' in the brain of schizophrenia? , 2011, Mini reviews in medicinal chemistry.

[3]  Patrick R Hof,et al.  Neuropathological findings in autism. , 2004, Brain : a journal of neurology.

[4]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. II. Validity. , 1989, Archives of general psychiatry.

[5]  E. Courchesne,et al.  Microglial Activation and Increased Microglial Density Observed in the Dorsolateral Prefrontal Cortex in Autism , 2010, Biological Psychiatry.

[6]  M. First,et al.  User's guide for the structured clinical interview for DSM-IV axis I disorders : SCID-I : clinical version , 1997 .

[7]  A. Scheibel,et al.  Lower Purkinje cell counts in the cerebella of four autistic subjects: initial findings of the UCLA-NSAC Autopsy Research Report. , 1986, The American journal of psychiatry.

[8]  N. Rooijen,et al.  Microglia Promote the Death of Developing Purkinje Cells , 2004, Neuron.

[9]  M. Giustetto,et al.  Synaptic Pruning by Microglia Is Necessary for Normal Brain Development , 2011, Science.

[10]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[11]  R. Ransohoff,et al.  Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. , 2006, Current opinion in immunology.

[12]  P. Bolton,et al.  Prevalence of autism-spectrum conditions: UK school-based population study , 2009, British Journal of Psychiatry.

[13]  B. Leventhal,et al.  The Autism Diagnostic Observation Schedule—Generic: A Standard Measure of Social and Communication Deficits Associated with the Spectrum of Autism , 2000, Journal of autism and developmental disorders.

[14]  S. Kanba,et al.  Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease. , 2009, Central nervous system agents in medicinal chemistry.

[15]  E. Courchesne,et al.  Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism , 2001, Biological Psychiatry.

[16]  Geraldine Dawson,et al.  Gray and white matter brain chemistry in young children with autism. , 2006, Archives of general psychiatry.

[17]  H. Kettenmann,et al.  Microglia: active sensor and versatile effector cells in the normal and pathologic brain , 2007, Nature Neuroscience.

[18]  J. Westlake,et al.  Brain-stem dysfunction in autism. Results of vestibular stimulation. , 1985, Archives of general psychiatry.

[19]  T. Kemper,et al.  Neuroanatomic observations of the brain in autism: a review and future directions , 2005, International Journal of Developmental Neuroscience.

[20]  Timothy A Keller,et al.  The nature of brain dysfunction in autism: functional brain imaging studies , 2010, Current opinion in neurology.

[21]  J. Nabekura,et al.  Resting Microglia Directly Monitor the Functional State of Synapses In Vivo and Determine the Fate of Ischemic Terminals , 2009, The Journal of Neuroscience.

[22]  J. Abkowitz,et al.  Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. , 1997, Blood.

[23]  M. Graeber Changing Face of Microglia , 2010, Science.

[24]  A. Torres,et al.  Strong association of the third hypervariable region of HLA-DRβ1 with autism , 1996, Journal of Neuroimmunology.

[25]  R. Banati,et al.  Visualising microglial activation in vivo , 2002, Glia.

[26]  Christina M. Morris,et al.  Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: A pregnant dam mouse model , 2009, Journal of Neuroimmunology.

[27]  Yasuomi Ouchi,et al.  Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. , 2010, Archives of general psychiatry.

[28]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[29]  Dick J. Veltman,et al.  SPM analysis of parametric (R)-[11C]PK11195 binding images: Plasma input versus reference tissue parametric methods , 2007, NeuroImage.

[30]  C. Pingree,et al.  Increased frequency of the null allele at the complement C4b locus in autism , 1991, Clinical and experimental immunology.

[31]  Cathleen K. Yoshida,et al.  Maternal Mid-Pregnancy Autoantibodies to Fetal Brain Protein: The Early Markers for Autism Study , 2008, Biological Psychiatry.

[32]  辻井 正次,et al.  論文抄読 Brain Serotonin and Dopamine Transporter Bindings in Adults with High-Functioning Autism , 2010 .

[33]  M. Tsujii,et al.  Evaluation of the Japanese version of the Developmental Coordination Disorder Questionnaire as a screening tool for clumsiness of Japanese children. , 2011, Research in developmental disabilities.

[34]  C. McDougle,et al.  Autism and immune factors: A comprehensive review , 2009 .

[35]  Paula Krakowiak,et al.  Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome , 2011, Brain, Behavior, and Immunity.

[36]  Y. Yoshihara,et al.  Plasma Cytokine Profiles in Subjects with High-Functioning Autism Spectrum Disorders , 2011, PloS one.

[37]  A. Bailey,et al.  A clinicopathological study of autism. , 1998, Brain : a journal of neurology.

[38]  S. Horvath,et al.  Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology , 2011, Nature.

[39]  R. Jones,et al.  Recognition of Faux Pas by Normally Developing Children and Children with Asperger Syndrome or High-Functioning Autism , 1999, Journal of autism and developmental disorders.

[40]  R. Ransohoff,et al.  Inflammatory Cell Migration into the Central Nervous System: A Few New Twists on an Old Tale , 2007, Brain pathology.

[41]  A. Zimmerman,et al.  Neuroglial activation and neuroinflammation in the brain of patients with autism , 2005, Annals of neurology.

[42]  David M. Rocke,et al.  A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins , 2007, Molecular Psychiatry.

[43]  H. Isoda,et al.  Metabolite alterations in the hippocampus of high-functioning adult subjects with autism. , 2010, The international journal of neuropsychopharmacology.

[44]  A. Blamire,et al.  Maternal neuronal antibodies associated with autism and a language disorder , 2003, Annals of neurology.

[45]  H. Neumann,et al.  Debris clearance by microglia: an essential link between degeneration and regeneration , 2008, Brain : a journal of neurology.

[46]  E. Bosmans,et al.  Increased serum albumin, γ globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism , 2002, Psychological Medicine.

[47]  Vincent J. Cunningham,et al.  Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model , 1997, NeuroImage.

[48]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[49]  P. Ashwood,et al.  The immune response in autism: a new frontier for autism research , 2006, Journal of leukocyte biology.

[50]  E. Audinat,et al.  Status Epilepticus Induces a Particular Microglial Activation State Characterized by Enhanced Purinergic Signaling , 2008, The Journal of Neuroscience.

[51]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[52]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[53]  M. Kikuchi,et al.  Reduced acetylcholinesterase activity in the fusiform gyrus in adults with autism spectrum disorders. , 2011, Archives of general psychiatry.

[54]  Douglas C. Miller,et al.  Refractory Epilepsy Associated With Microglial Activation , 2011, The neurologist.

[55]  Ralph-Axel Müller,et al.  Cerebellar function in autism: Functional magnetic resonance image activation during a simple motor task , 2004, Biological Psychiatry.

[56]  P. Rezaie,et al.  Colonisation of the developing human brain and spinal cord by microglia: a review , 1999, Microscopy research and technique.

[57]  Y. S. Kim,et al.  Prevalence of autism spectrum disorders in a total population sample. , 2011, The American journal of psychiatry.

[58]  A. Couteur,et al.  Autism Diagnostic Interview-Revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders , 1994, Journal of autism and developmental disorders.

[59]  S. Milstien,et al.  Cerebrospinal fluid and serum markers of inflammation in autism. , 2005, Pediatric neurology.

[60]  G. Kreutzberg Microglia: a sensor for pathological events in the CNS , 1996, Trends in Neurosciences.

[61]  W. McMahon,et al.  Confirmation of the association of the C4B null allelle in autism. , 2005, Human immunology.

[62]  E. Yoshikawa,et al.  Microglial activation and dopamine terminal loss in early Parkinson's disease , 2005, Annals of neurology.

[63]  A. Torres,et al.  Strong association of the third hypervariable region of HLA-DR beta 1 with autism. , 1996, Journal of neuroimmunology.

[64]  P. Rezaie,et al.  The origin and cell lineage of microglia—New concepts , 2007, Brain Research Reviews.

[65]  E. Bosmans,et al.  Activation of the Inflammatory Response System in Autism , 2002, Neuropsychobiology.

[66]  I. Hertz-Picciotto,et al.  Autism: maternally derived antibodies specific for fetal brain proteins. , 2007, Neurotoxicology.

[67]  Roger N Gunn,et al.  In-vivo measurement of activated microglia in dementia , 2001, The Lancet.

[68]  F. Peri,et al.  Microglia in the developing brain: from immunity to behaviour , 2011, Current Opinion in Neurobiology.

[69]  Janet B W Williams Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[70]  W. Streit,et al.  Role of microglia in the central nervous system's immune response , 2005, Neurological research.

[71]  I. Hertz-Picciotto,et al.  Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders , 2011, Journal of Neuroimmunology.